CTIS.eu › Cities › Czechia › Brandys Nad Labem
Brandys Nad Labem
Czechia
50 total trials
17 recruiting
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
2025-523486-17-00
5
Obesity
2025-523510-87-00
5
Obesity
2025-523106-32-00
5
2026-05-25
Obesity or Overweight and Type 2 Diabetes
2025-524265-24-00
5
2026-05-21
Dyslipidemia at High to Very High Cardiovascular Risk
2024-519870-38-00
5
2026-05-11
Atherosclerotic cardiovascular disease (ASCVD)
2025-523975-48-00
5
2026-05-08
Obesity
2025-523123-22-00
5
2026-05-07
Chronic Kidney Disease
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
2024-517866-40-00
4
2025-09-29
Moderate-to-severe Asthma
2024-519525-38-00
5
2025-08-22
Heart failure
2024-517991-39-00
5
2025-07-22
Asthma
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
2024-517458-90-00
5
2025-06-06
Chronic obstructive pulmonary disease (COPD)
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
2023-509706-30-00
5
2024-10-18
Heart failure (HF)
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
2023-504835-42-00
4
2024-02-29
Heart Failure (Heart Failure with Reduced Ejection Fraction)
2023-503224-66-00
5
2023-10-31
Atrial Fibrillation
2025-520521-21-00
5
2025-09-02
Hyperlipidemia
2024-515524-36-00
5
2025-05-30
Chronic Weight Management
2023-508039-29-00
4
2024-09-16
Moderate-to-severe Asthma
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
Showing 1–24 of 50 trials